HCM FY 2017 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$241M+11.6% YoY

Gross Profit

$65M27.1% margin

Operating Income

-$53M-22.1% margin

Net Income

-$27M-11.1% margin

EPS (Diluted)

$-0.22

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$14M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$598M

Total Liabilities

$113M

Stockholders' Equity

$462M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$241M	$216M	+11.6%
Gross Profit	$65M	$60M	+9.4%
Operating Income	-$53M	-$47M	-14.4%
Net Income	-$27M	$12M	-328.6%